Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CDA”

195 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 195 results

Not applicableNot Yet RecruitingNCT07708337
What this trial is testing

Evaluating Customized Antibiotic Duration (CDA) Strategy in Acute Exacerbations of COPD

Who this might be right for
COPDAcute Exacerbation of COPD
Capital Development Authority (CDA) 502
Not applicableUnknownNCT02489929
What this trial is testing

Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

Who this might be right for
Myeloid LeukemiaMyelodysplastic Syndromes
Assistance Publique Hopitaux De Marseille 35
Not applicableStudy completedNCT03646656
What this trial is testing

Heart Health Buddies: Peer Support to Decrease CVD Risk

Who this might be right for
Cardiovascular Disease
VA Office of Research and Development 15
Testing effectiveness (Phase 2)Looking for participantsNCT05657639
What this trial is testing

CAV Regimen for R/R AML

Who this might be right for
Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University 68
Not applicableLooking for participantsNCT07206095
What this trial is testing

Integrative Diagnosis for SCD and Other RADs

Who this might be right for
Sickle Cell DiseaseThalassaemiaCongenital Dyserythropoietic Anemia (CDA)+6 more
Hospital Universitari Vall d'Hebron Research Institute 200
Large-scale testing (Phase 3)UnknownNCT04880746
What this trial is testing

Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study

Who this might be right for
Peripheral T-cell Lymphoma
Ruijin Hospital 266
Not applicableLooking for participantsNCT06906185
What this trial is testing

Adaptation and Examination of a Trauma-informed Intervention for Pregnant Veterans

Who this might be right for
Trauma-related Mental Health Symptoms
VA Office of Research and Development 36
Testing effectiveness (Phase 2)UnknownNCT03181815
What this trial is testing

Cladribine in Combination With CAG in Patients With Refractory/Relapsed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaRelapse Leukemia
Sun Yat-sen University 48
Early research (Phase 1)Looking for participantsNCT06060782
What this trial is testing

Thiotepa, Cyclophosphamide, Clarithromycin and Cytarabine

Who this might be right for
Burkitt LymphomaLymphoblastic Lymphoma, AdultAcute Lymphoblastic Leukemia, Adult
Fifth Affiliated Hospital, Sun Yat-Sen University 28
Post-approval studies (Phase 4)Active Not RecruitingNCT04178005
What this trial is testing

Cladribine Tablets After Treatment With Natalizumab (CLADRINA)

Who this might be right for
Multiple Sclerosis
University of Texas Southwestern Medical Center 40
Testing effectiveness (Phase 2)UnknownNCT01513603
What this trial is testing

Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia

Who this might be right for
Acute Lymphoblastic LeukemiaLymphoblastic LymphomaBurkitts Leukemia/Lymphoma+1 more
New York Medical College 50
Not applicableStudy completedNCT03151083
What this trial is testing

Implementing and Evaluating Computer-Based Interventions for Mental Health: Testing an Implementation Strategy for VA Outpatient Care

Who this might be right for
Insomnia
VA Office of Research and Development 77
Testing effectiveness (Phase 2)Study completedNCT04195945
What this trial is testing

CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients

Who this might be right for
Acute Myeloid LeukemiaMyeloid Neoplasm
Fred Hutchinson Cancer Center 60
Not applicableStudy completedNCT03856320
What this trial is testing

Teaching Obesity Treatment Options to Adult Learners Trial

Who this might be right for
ObesityPatient EducationWeight Loss
VA Office of Research and Development 42
Large-scale testing (Phase 3)UnknownNCT05578378
What this trial is testing

Cladribine Combined With G-CSF and Cytarabine as a Salvage Treatment in R/R ALL

Who this might be right for
Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University 32
Not applicableLooking for participantsNCT06886425
What this trial is testing

Involvement of CDA and/or dCK Metabolizing Enzymes in the Response to Azacytidine Treatment of Patients With Hematologic Malignancies

Who this might be right for
Myelodysplastic Syndromes (MDS)Leukemia Acute Myeloid - AML
Assistance Publique Hopitaux De Marseille 70
Testing effectiveness (Phase 2)Looking for participantsNCT06532552
What this trial is testing

Comparison of VA (Venetoclax, Azacitidine), VACl (VA, Cladribine), VACh (VA, Chidamide), and Alternating VACl/VACh in Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia, AdultNewly Diagnosed
The First Affiliated Hospital of Soochow University 172
Not applicableStudy completedNCT04565899
What this trial is testing

Improving Care for Unhealthy Alcohol Use in Primary Care

Who this might be right for
Alcohol DrinkingAlcohol Use Disorder
VA Office of Research and Development 42
Early research (Phase 1)WithdrawnNCT03491579
What this trial is testing

Epacadostat, Cladribine and Cytarabine (ECC) in AML

Who this might be right for
AMLRelapse
Insel Gruppe AG, University Hospital Bern
Testing effectiveness (Phase 2)Looking for participantsNCT04047641
What this trial is testing

Cladribine, Idarubicin, Cytarabine, and Quizartinib in Treating Patients With Newly Diagnosed, Relapsed, or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

Who this might be right for
Acute Myeloid LeukemiaBlasts 20 Percent or More of Bone Marrow Nucleated CellsHigh Risk Myelodysplastic Syndrome+5 more
M.D. Anderson Cancer Center 80
Next Page